Literature DB >> 19156479

Persisting myocardial sympathetic dysfunction in takotsubo cardiomyopathy.

Hein J Verberne1, Dirk J van der Heijden, Berthe L F van Eck-Smit, G Aernout Somsen.   

Abstract

Entities:  

Mesh:

Year:  2009        PMID: 19156479      PMCID: PMC2697369          DOI: 10.1007/s12350-008-9017-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
A 73-year-old woman without a cardiovascular history was admitted with chest discomfort, dizziness, and nausea after an emotional meeting with the staff of a nursing home. She experienced the same complaints some years before when her father died. On admission the patient was in cardiogenic shock. Auscultation of the heart revealed a grade 3/6 systolic murmur radiating to the left axilla. The electrocardiography (ECG) showed an acute anterior wall infarction (Figure 1). Acute coronary angiography was performed but no significant coronary artery disease was found. Left ventricular (LV) angiography showed severe mitral regurgitation and apical ballooning (Figure 2). An intraventricular gradient of 100 mmHg was measured. Echocardiography showed apical akinesia and basal hyperkinesia resulting in severe mitral regurgitation due to systolic anterior movement of the anterior mitral valve leaflet. Troponin T (1.73 ng/L) and CK-MB (22 μg/L) were slightly increased. Based on these findings, the diagnosis of a takotsubo cardiomyopathy (TC) was made. Shortly after treatment with intravenous inotropics, and ACE inhibition the patient became hemodynamically stable and metoprolol was added.
Figure 1

ECG at admission suggestive for an acute anterior wall infarction: sinus-rhythm with 58 beats per minute, 1st degree AV block, ST segment elevation in leads V1-V4, and pathological Q waves in V2 and V3

Figure 2

Left ventricular (LV) angiography showing severe mitral regurgitation and apical ballooning

ECG at admission suggestive for an acute anterior wall infarction: sinus-rhythm with 58 beats per minute, 1st degree AV block, ST segment elevation in leads V1-V4, and pathological Q waves in V2 and V3 Left ventricular (LV) angiography showing severe mitral regurgitation and apical ballooning Cardiac MRI did not show late contrast enhancement which excludes myocardial fibrosis and myocardial infarction as the cause of the hemodynamic instability. Myocardial 123I-metaiodobenzylguanidine (123I-MIBG, a radiolabelled noradrenalin analog) scintigraphy, performed 4 days after admission, showed diffuse reduced myocardial uptake and increased washout of 123I-MIBG which reflects impaired sympathetic neuronal function and increased sympathetic activity, respectively (Figure 3A). Cardiac ultrasound was repeated at 3 and 7 months and showed no mitral regurgitation and a normalized LV function. However, cardiac sympathetic neuronal function and activity remained abnormal as was shown by 123I-MIBG scintigraphy at 3 and 7 months (Figure 3B and C, respectively).
Figure 3

123I-MIBG scintigraphy: images on the left were made 15 min postinjection (p.i.) of 123I-MIBG (early) and the images on the right were made 4 h p.i. (late). Upper left panel shows the regions of interest over the myocardium and mediastinum for the calculation of the semiquantitative parameters of 123I-MIBG myocardial uptake and washout. 123I-MIBG images 4 days after hospital admission, show severely reduced myocardial uptake (A). Semiquantitative analysis of the myocardial uptake confirmed the visual interpretation (early heart/mediastinal (H/M) ratio: 1.54, late H/M: 1.26 and myocardial washout of 123I-MIBG: 18%). Three (B) and seven months (C) after hospital admission 123I-MIBG myocardial uptake and washout remained abnormal. The semiquantitative parameters remained abnormal after 3 months (early H/M: 1.78, late H/M: 1.33, and myocardial washout of 123I-MIBG: 25%) and after 7 months (early H/M: 1.66, late H/M: 1.13, and myocardial washout of 123I-MIBG: 32%). Due to the diffuse reduced myocardial 123I-MIBG uptake SPECT images could not reliably be reconstructed

123I-MIBG scintigraphy: images on the left were made 15 min postinjection (p.i.) of 123I-MIBG (early) and the images on the right were made 4 h p.i. (late). Upper left panel shows the regions of interest over the myocardium and mediastinum for the calculation of the semiquantitative parameters of 123I-MIBG myocardial uptake and washout. 123I-MIBG images 4 days after hospital admission, show severely reduced myocardial uptake (A). Semiquantitative analysis of the myocardial uptake confirmed the visual interpretation (early heart/mediastinal (H/M) ratio: 1.54, late H/M: 1.26 and myocardial washout of 123I-MIBG: 18%). Three (B) and seven months (C) after hospital admission 123I-MIBG myocardial uptake and washout remained abnormal. The semiquantitative parameters remained abnormal after 3 months (early H/M: 1.78, late H/M: 1.33, and myocardial washout of 123I-MIBG: 25%) and after 7 months (early H/M: 1.66, late H/M: 1.13, and myocardial washout of 123I-MIBG: 32%). Due to the diffuse reduced myocardial 123I-MIBG uptake SPECT images could not reliably be reconstructed The diagnosis of a stress-induced cardiomyopathy, apical ballooning syndrome or TC was based on the presence of the typical symptoms and signs of an anterior wall infarction after a highly stressful moment (a lifetime crisis), combined with normal coronary angiography, LV apical ballooning, no signs of late contrast enhancement on MRI scanning, and rapid recovery of LV function.1 The name Takotsubo is related to the morphology of the left ventricle, which shows resemblance to a Japanese round-bottomed narrow-necked fishing pot used for trapping octopus. Postmenopausal women seem to be most at risk for developing this syndrome, especially after an episode of acute emotional stress. In a systematic review, women accounted for 82-100% of patients with an average age of 62-75 years, although cases have been described in individuals aged 10-91 years.2 Formal diagnostic criteria have yet to be established. Bybee et al have suggested diagnostic criteria for TC, requiring the following: (1) transient LV wall motion abnormalities involving the apical and/or midventricular myocardial segments with wall motion abnormalities extending beyond a single epicardial coronary distribution; (2) absence of obstructive epicardial CAD or angiographic evidence of acute plaque rupture that could be responsible for the observed wall motion abnormality; and (3) new ECG abnormalities such as transient ST-segment elevation and/or diffuse T-wave inversions or Troponin T elevation.2-4 Although the exact pathophysiology of TC is unknown, it has been suggested that catecholamine-mediated cardiac toxicity is related to the pathophysiological basis of TC. In these patients, increased myocardial sympathetic activity is caused by increased presynaptic release and reduced re-uptake of noradrenalin. This leads to down regulation and desensitization of the postsynaptic cardiac β-adrenoreceptors, leading to a further decline of the LV function.5 The changes in the presynaptic myocardial sympathetic activity can be assessed with the radio-labeled noradrenalin analog 123I-MIBG.6 However, it has been shown that some β-adrenoreceptor-blockers may influence myocardial 123I-MIBG uptake. This has also been suggested for ACE-inhibitors. This may explain in part the initial scintigraphic findings. However, in the case report of Moreo et al 123I-MIBG myocardial uptake increased, after a 2-month treatment with carvedilol.6 Moreover, in patients with heart failure β-adrenoreceptor-blockers and ACE inhibitors are associated with an increase in 123I-MIBG uptake and reduced washout.7,8 In our patient ACE inhibition was discontinued after the acute phase and the β-adrenoreceptor-blocker was continued. Another possible confounding factor of persisting abnormal 123I-MIBG scintigraphic findings is denervation due to a previous myocardial infarction. However, MRI showed no signs of a previous myocardial infarction. Taken together it is likely that the scintigraphic images, at presentation and during follow-up, reflect true persisting increased myocardial sympathetic activity. Another possible pathophysiological mechanism for the development of TC might be related to stress-induced coronary epicardial spasm or endothelial dysfunction resulting in myocardial stunning. In a recent study, Sato et al evaluated coronary artery endothelial dysfunction in 35 patients with TC.9 In 54% of patients with TC, diffuse coronary vasoconstriction occurred after intracoronary acetylcholine provocation. In the acute phase, myocardial perfusion and myocardial fatty acid metabolism scintigraphy (123I-BMIPP) were impaired. During follow-up myocardial perfusion and myocardial fatty acid metabolism improved to normal in association with improvement of LV function. Myocardial stunning due to stress-induced coronary epicardial spasm or endothelial dysfunction might therefore be a likely explanation for TC. Assessment of myocardial perfusion with SPECT and PET tracers and assessment of glucose metabolism with 18F-FDG have been used to evaluate TC patients.10-15 Typically in the early/acute phase of TC myocardial perfusion can be (regionally, i.e., apex) disturbed and shows an impaired (regional, i.e., apex) coronary flow reserve (CFR) and a more pronounced impairment of (regional, i.e., apex) myocardial glucose metabolism. In general, the regional reduction of perfusion and impairment of glucose metabolism have the tendency to resolve completely 3 months after the early/acute phase. In our patient, myocardial sympathetic activity was increased in the early phase of TC. Although LV function was completely normalized, increased myocardial sympathetic activity persisted. Normalization of myocardial 123I-MIBG uptake has been described in several case reports.6,16 This is the first report showing persisting sympathetic dysfunction in a patient with TC after complete normalization of the LV function and no signs of late enhancement on MRI. The recurrence of TC is rare and is estimated at 2.9% per year and the overall cardiovascular survival is not different from age- and gender-matched controls.17 Echocardiographic follow-up of TC patients has never been performed in a consistent way. This may implicate that the recurrence rate of TC is underestimated. In the present case, the patient experienced the same symptoms after an emotional event several years earlier which may have been an earlier episode of TC. Predictors of TC recurrence are not known. As TC is associated with a hyperadrenergic state, the persisting increased myocardial sympathetic activity may have prognostic implications.18 Therefore, myocardial 123I-MIBG scintigraphy may identify patients at risk for the recurrence of TC. These findings may warrant extensive pharmacological therapy and follow-up in TC patients. Theoretically, recurrence rates may be lower in those who are maintained on adrenergic blockade assuming that catecholamines play a central role in the pathogenesis of the syndrome.
  18 in total

Review 1.  Stress-related cardiomyopathy syndromes.

Authors:  Kevin A Bybee; Abhiram Prasad
Journal:  Circulation       Date:  2008-07-22       Impact factor: 29.690

Review 2.  Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors.

Authors:  R J Lefkowitz; M G Caron; G L Stiles
Journal:  N Engl J Med       Date:  1984-06-14       Impact factor: 91.245

3.  Acute and reversible cardiomyopathy provoked by stress in women from the United States.

Authors:  Scott W Sharkey; John R Lesser; Andrey G Zenovich; Martin S Maron; Jana Lindberg; Terrence F Longe; Barry J Maron
Journal:  Circulation       Date:  2005-02-01       Impact factor: 29.690

4.  Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure.

Authors:  G A Somsen; B van Vlies; P A de Milliano; J J Borm; E A van Royen; E Endert; K I Lie
Journal:  Heart       Date:  1996-09       Impact factor: 5.994

Review 5.  Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction.

Authors:  Kevin A Bybee; Tomas Kara; Abhiram Prasad; Amir Lerman; Greg W Barsness; R Scott Wright; Charanjit S Rihal
Journal:  Ann Intern Med       Date:  2004-12-07       Impact factor: 25.391

6.  Neurohumoral features of myocardial stunning due to sudden emotional stress.

Authors:  Ilan S Wittstein; David R Thiemann; Joao A C Lima; Kenneth L Baughman; Steven P Schulman; Gary Gerstenblith; Katherine C Wu; Jeffrey J Rade; Trinity J Bivalacqua; Hunter C Champion
Journal:  N Engl J Med       Date:  2005-02-10       Impact factor: 91.245

7.  Beneficial effects of metoprolol on myocardial sympathetic function: Evidence from a randomized, placebo-controlled study in patients with congestive heart failure.

Authors:  Paul A R de Milliano; Andre C de Groot; Jan G P Tijssen; Berthe L F van Eck-Smit; Pieter A Van Zwieten; Kong I Lie
Journal:  Am Heart J       Date:  2002-08       Impact factor: 4.749

8.  Reversible impairment of coronary flow reserve in takotsubo cardiomyopathy: a myocardial PET study.

Authors:  Mauro Feola; Stephane Chauvie; Gian Luca Rosso; Alberto Biggi; Flavio Ribichini; Marco Bobbio
Journal:  J Nucl Cardiol       Date:  2008-07-31       Impact factor: 5.952

9.  Stunned myocardium in transient left ventricular apical ballooning: a serial study of dual I-123 BMIPP and Tl-201 SPECT.

Authors:  Akira Sato; Kazutaka Aonuma; Toshihiro Nozato; Yukio Sekiguchi; Osamu Okazaki; Kazuo Kubota; Michiaki Hiroe
Journal:  J Nucl Cardiol       Date:  2008-06-12       Impact factor: 5.952

10.  Nuclear medicine imaging of takotsubo cardiomyopathy: typical form and midventricular ballooning syndrome.

Authors:  Sébastien Cimarelli; Alessio Imperiale; Dorra Ben-Sellem; Jérôme Rischner; Julien Detour; Olivier Morel; Patrick Ohlmann; André Constantinesco
Journal:  J Nucl Cardiol       Date:  2007-12-21       Impact factor: 5.952

View more
  9 in total

1.  Myocardial perfusion scintigraphy during chest pain: An atypical presentation of takotsubo cardiomyopathy?

Authors:  Maria Marta Maggiotto Sabra; Fernanda Salomão Costa; Jader Cunha de Azevedo; Claudio Tinoco Mesquita; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2018-05-29       Impact factor: 5.952

2.  Initial clinical presentation of Takotsubo cardiomyopathy with-a focus on electrocardiographic changes: A literature review of cases.

Authors:  Erick Francisco Sanchez-Jimenez
Journal:  World J Cardiol       Date:  2013-07-26

3.  The natural history of takotsubo syndrome: a two-year follow-up study with myocardial sympathetic and perfusion G-SPECT imaging.

Authors:  Stelvio Sestini; Francesco Pestelli; Mario Leoncini; Francesco Bellandi; Christian Mazzeo; Luigi Mansi; Ignasi Carrio; Antonio Castagnoli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-12-01       Impact factor: 9.236

Review 4.  Cardiac 123I-mIBG Imaging in Heart Failure.

Authors:  Derk O Verschure; Kenichi Nakajima; Hein J Verberne
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-25

Review 5.  Tako-tsubo cardiomyopathy: how to understand possible pathophysiological mechanism and the role of (123)I-MIBG imaging.

Authors:  Derk O Verschure; G Aernout Somsen; Berthe L F van Eck-Smit; Remco J J Knol; Jan Booij; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2014-01-25       Impact factor: 5.952

6.  International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology.

Authors:  Jelena-Rima Ghadri; Ilan Shor Wittstein; Abhiram Prasad; Scott Sharkey; Keigo Dote; Yoshihiro John Akashi; Victoria Lucia Cammann; Filippo Crea; Leonarda Galiuto; Walter Desmet; Tetsuro Yoshida; Roberto Manfredini; Ingo Eitel; Masami Kosuge; Holger M Nef; Abhishek Deshmukh; Amir Lerman; Eduardo Bossone; Rodolfo Citro; Takashi Ueyama; Domenico Corrado; Satoshi Kurisu; Frank Ruschitzka; David Winchester; Alexander R Lyon; Elmir Omerovic; Jeroen J Bax; Patrick Meimoun; Guiseppe Tarantini; Charanjit Rihal; Shams Y-Hassan; Federico Migliore; John D Horowitz; Hiroaki Shimokawa; Thomas Felix Lüscher; Christian Templin
Journal:  Eur Heart J       Date:  2018-06-07       Impact factor: 29.983

7.  Quadruple episodes of takotsubo cardiomyopathy: a case report.

Authors:  Takashi Hiruma; Ryosuke Higuchi; Nobuo Iguchi
Journal:  Eur Heart J Case Rep       Date:  2021-01-16

Review 8.  Current Knowledge and Future Challenges in Takotsubo Syndrome: Part 1-Pathophysiology and Diagnosis.

Authors:  Elias Rawish; Thomas Stiermaier; Francesco Santoro; Natale D Brunetti; Ingo Eitel
Journal:  J Clin Med       Date:  2021-01-28       Impact factor: 4.241

Review 9.  Cardiac sympathetic activity in hypertrophic cardiomyopathy and Tako-tsubo cardiomyopathy.

Authors:  Derk O Verschure; Berthe L F van Eck-Smit; G Aernout Somsen; Hein J Verberne
Journal:  Clin Transl Imaging       Date:  2015-08-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.